Insulet Corp Enters Material Definitive Agreement

TL;DR

Insulet Corp just signed a big deal, likely a new loan or financial obligation.

AI Summary

On March 20, 2025, Insulet Corporation entered into a material definitive agreement related to a direct financial obligation. The company, incorporated in Delaware with its principal executive offices in Acton, Massachusetts, filed this 8-K report on March 21, 2025. The filing indicates a significant financial event for the company.

Why It Matters

This filing signals a significant financial commitment or obligation for Insulet Corporation, which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Entering into material definitive agreements, especially those involving financial obligations, can introduce financial risks and impact a company's balance sheet.

Key Players & Entities

• INSULET CORP (company) — Registrant
• March 20, 2025 (date) — Date of earliest event reported
• March 21, 2025 (date) — Date of Report
• Delaware (jurisdiction) — State of Incorporation
• 001-33462 (identifier) — SEC File Number
• 100 Nagog Park, Acton, Massachusetts 01720 (address) — Address of Principal Executive Offices
• (978) 600-7000 (phone_number) — Registrant's telephone number

FAQ

From the Filing

0001193125-25-059783.txt : 20250321 0001193125-25-059783.hdr.sgml : 20250321 20250321075538 ACCESSION NUMBER: 0001193125-25-059783 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250320 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250321 DATE AS OF CHANGE: 20250321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSULET CORP CENTRAL INDEX KEY: 0001145197 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043523891 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33462 FILM NUMBER: 25758539 BUSINESS ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-600-7000 MAIL ADDRESS: STREET 1: 100 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 d825270d8k.htm 8-K 8-K INSULET CORP false 0001145197 0001145197 2025-03-20 2025-03-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): March 21, 2025 ( March 20, 2025 ) INSULET CORPORATION (Exact Name of Registrant as Specified in Charter)   Delaware   001-33462   04-3523891 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)     100 Nagog Park ,   Acton   Massachusetts   01720 (Address of Principal Executive Offices, including Zip Code) Registrant’s telephone number, including area code: (978) 600-7000 Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.            ☐ Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.001 Par Value Per Share   PODD   The NASDAQ Stock Market, LLC Item 1.01 Entry into a Material Definitive Agreement. Indenture On March 20, 2025 (the “Closing Date”), Insulet Corporation (the “Company”) closed its previously announced issuance and sale of $450 million aggregate principal amount of the Company’s 6.50% Senior Notes due 2033 (the “Notes”). The estimated net proceeds from the offering are expected to be approximately $444 million, after deducting the initial purchasers’ discount